Author(s):
Divya Tamboli, Vandana Yadav, Sarang Bali, Renu Das
Email(s):
anishc@cecbilaspur.ac.in
DOI:
10.52711/2321-5836.2026.00019 
Address:
Divya Tamboli1, Vandana Yadav2, Sarang Bali2, Renu Das2
1Students, School of Pharmacy, Chouksey Engineering College, Bilaspur (CG) India.
2Assistant Professor, School of Pharmacy, Chouksey Engineering College, Bilaspur (CG)
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2026
ABSTRACT:
Progressive neuronal loss, oxidative stress, and neuroinflammation are hallmarks of neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's, which eventually result in cognitive decline. Using natural products to target neuroinflammatory pathways has become a promising therapeutic approach for neuroprotection. Indole alkaloids, flavonoids, terpenoids, and phenolic components have notable pharmacological effects in neurodegeneration. These bioactive substances are found in Tabernaemontana divaricata, a medicinal plant belonging to Apocynaceae family. The current article emphasizes T. divaricata's neuroprotective potential and its possible contribution to reducing cognitive impairment brought on by neuroinflammation. Pharmacological and experimental research indicates that the plant has potent anti-inflammatory and antioxidant qualities. It can scavenge free radicals, prevent lipid peroxidation, and reduce pro-inflammatory cytokines like TNF-a, IL-1ß, and IL-6. Furthermore, by inhibiting acetylcholinesterase, its bioactive chemicals may improve cholinergic neurotransmission and promote neuronal survival by preserving neurotrophic factors like brain-derived neurotrophic factor (BDNF). Together, these processes enhance neuronal protection, synaptic plasticity, and cognitive performance. With all factors considered, T. divaricata shows encouraging neuroprotective potential and could be a useful natural medicinal option for the treatment of neurodegenerative diseases linked to neuroinflammation.
Cite this article:
Divya Tamboli, Vandana Yadav, Sarang Bali, Renu Das. Neuroprotective effect of Tabernaemontana divaricata against LPS-Induced Neuroinflammation and Spatial Memory Loss in rats. Research Journal of Pharmacology and Pharmacodynamics.2026;18(2):140-6. doi: 10.52711/2321-5836.2026.00019
Cite(Electronic):
Divya Tamboli, Vandana Yadav, Sarang Bali, Renu Das. Neuroprotective effect of Tabernaemontana divaricata against LPS-Induced Neuroinflammation and Spatial Memory Loss in rats. Research Journal of Pharmacology and Pharmacodynamics.2026;18(2):140-6. doi: 10.52711/2321-5836.2026.00019 Available on: https://rjppd.org/AbstractView.aspx?PID=2026-18-2-4
1REFERENCES:
1. Kumar, A., Singh, S., and Ekavali. A review on neurodegenerative disorders: Pathophysiology and potential therapeutic approaches. Neuroscience Letters. 2023; 801: 137207. https://doi.org/10.1016/j.neulet.2023.137207.
2. Singh, N., and Parle, M. The neuroprotective role of medicinal plants and their bioactive compounds in Alzheimer’s disease: A review. Phytotherapy Research. 2020; 34(6): 1291–1310. https://doi.org/10.1002/ptr.6604
3. Rajesh, V., George, B. P., and Abrahamse, H. Neuroprotective and antioxidant potential of indole alkaloids from Tabernaemontana species: A review. Phytomedicine. 2021. https://doi.org/10.1016/j.phymed.2021.153553.
4. Rumzhum, N. N., Rahman, M. S., and Kazal, M. K. Evaluation of antioxidant, cytotoxic and antimicrobial activity of Tabernaemontana divaricata flower. British Journal of Pharmaceutical Research. 2012; 2(2): 74–91. https://doi.org/10.9734/BJPR/2012/1284
5. Pratchayasakul, W., Pongchaidecha, A., Chattipakorn, N., and Chattipakorn, S. C. Ethnobotany and pharmacological activities of Tabernaemontana divaricata. Indian Journal of Medical Research. 2008; 127(4): 317–335.
6. Saini, R., Sharma, P., and Kaur, J. Acetylcholinesterase inhibitory and memory-enhancing potential of Tabernaemontana divaricata leaf extract in experimental models. Journal of Ethnopharmacology. 2024; 321: 117245. https://doi.org/10.1016/j.jep.2024.117245
7. Amraie, E., Jafarian, I., Gholami, M., and Hosseini, M. Neuroprotective effects of antioxidant therapy on hippocampal neurons and cognitive function: Mechanistic insights. Neurochemical Research. 2020; 45(8): 1789–1802. https://doi.org/10.1007/s11064-020-03031-4
8. Kokate, C. K., Purohit, A. P., and Gokhale, S. B. Pharmacognosy (52nd ed.). Nirali Prakashan. 2019
9. CPCSEA. Guidelines for laboratory animal facility. Committee for the Purpose of Control and Supervision of Experiments on Animals, Ministry of Environment, Forest and Climate Change, Government of India. 2018
10. Turner, P. V., Brabb, T., Pekow, C., and Vasbinder, M. A. Administration of substances to laboratory animals: Routes of administration and factors to consider. Journal of the American Association for Laboratory Animal Science. 2011; 50(5): 600–613.
11. Zhao, J., Bi, W., Xiao, S., Lan, X., Cheng, X., Zhang, J., ... and Fu, Y. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Scientific. 2019. https://doi.org/10.1038/s41598-019-42286-8.
12. Zhang, X., Wang, Y., Dong, H., Xu, Y., and Zhang, S. Induction of microglial activation and neuroinflammation by lipopolysaccharide in rodents: A review of mechanisms and therapeutic approaches. Progress in NeuroPsychopharmacology and Biological Psychiatry. 2018; 85: 1–12. https://doi.org/10.1016/j.pnpbp.2018.04.012.